Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
Zhouwei Xu, Aven Lee, Amanda Nouwens, Robert David Henderson & Pamela Ann McCombe. (2018) Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 362-376.
Read now
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Read now
Elizabeth Gray, James R. Larkin, Tim D. W. Claridge, Kevin Talbot, Nicola R. Sibson & Martin R. Turner. (2015) The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 456-463.
Read now
Read now
Michael E. Bozik, Hiroshi Mitsumoto, Benjamin R. Brooks, Stacy A. Rudnicki, Dan H. Moore, Bing Zhang, Albert Ludolph, Merit E. Cudkowicz, Leonard H. van den Berg, James Mather, Thomas Petzinger$suffix/text()$suffix/text() & Donald Archibald. (2014) A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 406-413.
Read now
Read now
Kay A. Lawton, Meredith V. Brown, Danny Alexander, Zhen Li, Jacob E. Wulff, Robert Lawson, Matt Jaffa, Mike V. Milburn, John A. Ryals, Robert Bowser, Merit E. Cudkowicz & James D. Berry. (2014) Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 362-370.
Read now
Read now
Martin R. Turner, Robert Bowser, Lucie Bruijn, Luc Dupuis, Albert Ludolph, Michael McGrath, Giovanni Manfredi, Nicholas Maragakis, Robert G. Miller, Seth L. Pullman, Seward B. Rutkove, Pamela J. Shaw, Jeremy Shefner & Kenneth H. Fischbeck. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup1, pages 19-32.
Read now
Read now
Christiaan G. J. Saris, Ewout J. N. Groen, Paul W. J. Van Vught, Michael A. van Es, Hylke M. Blauw, Jan H. Veldink & Leonard H. van den Berg. (2013) Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:3, pages 190-198.
Read now
Read now
Articles from other publishers (66)
Lucas Vu, Krystine Garcia‐Mansfield, Antonio Pompeiano, Jiyan An, Victoria David‐Dirgo, Ritin Sharma, Vinisha Venugopal, Harkeerat Halait, Guido Marcucci, Ya‐Huei Kuo, Lisa Uechi, Russell C. Rockne, Patrick Pirrotte & Robert Bowser. (2023)
Proteomics and mathematical modeling of longitudinal
CSF
differentiates fast versus slow
ALS
progression
. Annals of Clinical and Translational Neurology 10:11, pages 2025-2042.
Crossref
Crossref
Aven Lee, Robert Henderson, Buddhika Jayakody Arachchige, Thomas Robertson & Pamela Ann McCombe. (2023) Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms. Journal of the Neurological Sciences 452, pages 120753.
Crossref
Crossref
Scott P. Allen, Afnan Al Sultan, Elaine Kabucho Kibirige, Erin Tonkiss, Keaton J. Hamer, Lydia M. Castelli, Ya-Hui Lin, Sarah Roscoe, Nikolaos Stefanidis, Richard J. Mead, J. Robin Highley, Johnathan Cooper-Knock, Guillaume M. Hautbergue, Paul R. Heath, Janine Kirby & Pamela J. Shaw. (2023) A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Stephen A. Goutman, Jonathan Boss, Gayatri Iyer, Hani Habra, Masha G. Savelieff, Alla Karnovsky, Bhramar Mukherjee & Eva L. Feldman. (2022) Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle & Nerve 67:3, pages 208-216.
Crossref
Crossref
Stephen A Goutman, Kai Guo, Masha G Savelieff, Adam Patterson, Stacey A Sakowski, Hani Habra, Alla Karnovsky, Junguk Hur & Eva L Feldman. (2022) Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts. Brain 145:12, pages 4425-4439.
Crossref
Crossref
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz & J. Alex Parker. (2022) Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 5:1.
Crossref
Crossref
Gavin McCluskey, Colette Donaghy, Karen E. Morrison, John McConville, William Duddy & Stephanie Duguez. (2022) The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. Journal of Personalized Medicine 12:9, pages 1418.
Crossref
Crossref
Kelby M. Killoy, Benjamin A. Harlan, Mariana Pehar & Marcelo R. Vargas. (2022) NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons. The FASEB Journal 36:4.
Crossref
Crossref
Vivek P. Chavda, Chirag Patel, Dharti Modh, Yavuz Nuri Ertas, Shreya S. Sonak, Nafesa K. Munshi, Krishnan Anand, Arun Soni & Sonal Pande. (2022) Therapeutic Approaches to Amyotrophic Lateral Sclerosis from the Lab to the Clinic. Current Drug Metabolism 23:3, pages 200-222.
Crossref
Crossref
Suvithanandhini Loganathan, Bryce A. Wilson, Sara B. Carey, Ernesto Manzo, Archi Joardar, Berrak Ugur & Daniela C. Zarnescu. (2022) TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS. Metabolites 12:2, pages 101.
Crossref
Crossref
Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, Lokesh Agrawal, Cao Hongyi & Sanjib Bhattacharyya. (2021) Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment. Metabolic Brain Disease 37:1, pages 67-104.
Crossref
Crossref
Yaping Shao, Xiaojiao Xu, Nanxing Wang, Guowang Xu & Weidong Le. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
181
213
.
Kuo-Hsuan Chang, Chia-Ni Lin, Chiung-Mei Chen, Rong-Kuo Lyu, Chun-Che Chu, Ming-Feng Liao, Chin-Chang Huang, Hong-Shiu Chang, Long-Sun Ro & Hung-Chou Kuo. (2021) Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis. Biomedicines 9:12, pages 1944.
Crossref
Crossref
Rui Jia, Qiaoyi Chen, Qingqing Zhou, Ronghua Zhang, Jiaoting Jin, Fangfang Hu, Xiao Liu, Xing Qin, Li Kang, Songzhen Zhao, Yonghui Dang & Jingxia Dang. (2021) Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry. Scientific Reports 11:1.
Crossref
Crossref
Pratishtha Chatterjee, Yeo‐Jin Cheong, Atul Bhatnagar, Kathryn Goozee, Yunqi Wu, Matthew McKay, Ian J. Martins, Wei L. F. Lim, Steve Pedrini, Michelle Tegg, Victor L. Villemagne, Prita R. Asih, Preeti Dave, Tejal M. Shah, Cintia B. Dias, Stephanie J. Fuller, Heidi Hillebrandt, Sunil Gupta, Eugene Hone, Kevin Taddei, Henrik Zetterberg, Kaj Blennow, Hamid R. Sohrabi & Ralph N. Martins. (2020) Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. Journal of Neurochemistry 159:2, pages 389-402.
Crossref
Crossref
Mengmeng Wang, Dandan Liu, Zhizhong Zhang, Wei Xie, Liping Cao, Linfeng Zhu, Meng Liu, Shiying Sheng & Xuegan Lian. (2021) Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study. Molecular Neurobiology 58:6, pages 2910-2915.
Crossref
Crossref
T.J. Tracey, S.E. Kirk, F.J. Steyn & S.T. Ngo. (2021) The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Seminars in Cell & Developmental Biology 112, pages 69-81.
Crossref
Crossref
Zhuozhi Dai, Sanjay Kalra, Dennell Mah, Peter Seres, Hongfu Sun, Renhua Wu & Alan H. Wilman. (2020) Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients. European Radiology 31:3, pages 1401-1409.
Crossref
Crossref
Kelby M. Killoy, Mariana Pehar, Benjamin A. Harlan & Marcelo R. Vargas. (2021) Altered expression of clock and clock‐controlled genes in a hSOD1‐linked amyotrophic lateral sclerosis mouse model. The FASEB Journal 35:2.
Crossref
Crossref
Stephen A Goutman, Jonathan Boss, Kai Guo, Fadhl M Alakwaa, Adam Patterson, Sehee Kim, Masha Georges Savelieff, Junguk Hur & Eva L Feldman. (2020) Untargeted metabolomics yields insight into ALS disease mechanisms. Journal of Neurology, Neurosurgery & Psychiatry 91:12, pages 1329-1338.
Crossref
Crossref
Qiuying Chen, Csaba Konrad, Davinder Sandhu, Dipa Roychoudhury, Benjamin I. Schwartz, Roger R. Cheng, Kirsten Bredvik, Hibiki Kawamata, Elizabeth L. Calder, Lorenz Studer, Steven.M. Fischer, Giovanni Manfredi & Steven.S. Gross. (2020) Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients. Neurobiology of Disease 144, pages 105025.
Crossref
Crossref
Jeffrey L. Neul, Steven A. Skinner, Fran Annese, Jane Lane, Peter Heydemann, Mary Jones, Walter E. Kaufmann, Daniel G. Glaze & Alan K. Percy. (2020) Metabolic Signatures Differentiate Rett Syndrome From Unaffected Siblings. Frontiers in Integrative Neuroscience 14.
Crossref
Crossref
Mara-Luciana Floare & Scott P. Allen. (2020) Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights 15, pages 263310552095730.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Luciana M. Pujol-Lereis. (2019) Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases. International Journal of Molecular Sciences 20:14, pages 3564.
Crossref
Crossref
Ernesto Manzo, Ileana Lorenzini, Dianne Barrameda, Abigail G O'Conner, Jordan M Barrows, Alexander Starr, Tina Kovalik, Benjamin E Rabichow, Erik M Lehmkuhl, Dakotah D Shreiner, Archi Joardar, Jean-Charles Liévens, Robert Bowser, Rita Sattler & Daniela C Zarnescu. (2019) Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife 8.
Crossref
Crossref
Gavin Pharaoh, Kavithalakshmi Sataranatarajan, Kaitlyn Street, Shauna Hill, Jake Gregston, Bumsoo Ahn, Caroline Kinter, Michael Kinter & Holly Van Remmen. (2019) Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice. Frontiers in Neuroscience 13.
Crossref
Crossref
Udaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, Anthony J. Bjourson, William Duddy & Stephanie Marie-Rose Duguez. (2019) A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Kjetil Bjornevik, Zhongli ZhangÉilis J. O'ReillyJames D. BerryClary B. Clish, Amy DeikSarah JeanfavreIkuko KatoRachel S. KellyLaurence N. KolonelLiming LiangLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniKerry A. PierceMichael A. SchwarzschildAladdin H. ShadyabJean Wactawski-WendeDong D. WangYing WangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Crossref
Kjetil BjornevikÉilis J. O'ReillyJames D. BerryClary B. ClishSarah JeanfavreIkuko KatoLaurence N. KolonelLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniMichael A. SchwarzschildEvelyn O. TalbottRobert B. WallaceZhongli ZhangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Ali Jawaid, Romesa Khan, Magdalini Polymenidou & Paul E. Schulz. (2018) Disease-modifying effects of metabolic perturbations in ALS/FTLD. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Carla Brancia, Barbara Noli, Marina Boido, Roberta Pilleri, Andrea Boi, Roberta Puddu, Francesco Marrosu, Alessandro Vercelli, Paolo Bongioanni, Gian-Luca Ferri & Cristina Cocco. (2018) TLQP Peptides in Amyotrophic Lateral Sclerosis: Possible Blood Biomarkers with a Neuroprotective Role. Neuroscience 380, pages 152-163.
Crossref
Crossref
Ernesto Manzo, Abigail G. O'Conner, Jordan M. Barrows, Dakotah D. Shreiner, Gabriel J. Birchak & Daniela C. Zarnescu. (2018) Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink & Leonard H van den Berg. (2018) Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 89:2, pages 156-161.
Crossref
Crossref
Tara Kashav & Vijay Kumar. 2018. Systems Biology. Systems Biology
59
75
.
Archi Joardar, Ernesto Manzo & Daniela C. Zarnescu. (2017) Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Current Genetic Medicine Reports 5:2, pages 108-114.
Crossref
Crossref
Jie Guo, Xuan Yang, Lina Gao & Dawei Zang. (2017) Evaluating the levels of CSF and serum factors in ALS. Brain and Behavior 7:3, pages e00637.
Crossref
Crossref
Jong-Min Lee, Vanessa Tan, David Lovejoy, Nady Braidy, Dominic B. Rowe, Bruce J. Brew & Gilles J. Guillemin. (2017) Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis. Neuropharmacology 112, pages 346-364.
Crossref
Crossref
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Crossref
Charlotte Veyrat-Durebex, Philippe Corcia, Eric Piver, David Devos, Audrey Dangoumau, Flore Gouel, Patrick Vourc’h, Patrick Emond, Frédéric Laumonnier, Lydie Nadal-Desbarats, Paul H Gordon, Christian R Andres & Hélène Blasco. (2015) Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis. Molecular Neurobiology 53:10, pages 6910-6924.
Crossref
Crossref
Medi KoriBusra AydınSemra UnalKazim Yalcin ArgaDilek Kazan. (2016) Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. OMICS: A Journal of Integrative Biology 20:11, pages 645-661.
Crossref
Crossref
Junfang Wu, Anna Wuolikainen, Miles Trupp, Pär Jonsson, Stefan L. Marklund, Peter M. Andersen, Lars Forsgren & Anders Öhman. (2016) NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects. Metabolomics 12:6.
Crossref
Crossref
Júlia Costa & Mamede de Carvalho. (2016) Emerging molecular biomarker targets for amyotrophic lateral sclerosis. Clinica Chimica Acta 455, pages 7-14.
Crossref
Crossref
Taku Hatano, Shinji Saiki, Ayami Okuzumi, Robert P Mohney & Nobutaka Hattori. (2016) Identification of novel biomarkers for Parkinson's disease by metabolomic technologies. Journal of Neurology, Neurosurgery & Psychiatry 87:3, pages 295-301.
Crossref
Crossref
H. Blasco, F. Patin, B. Madji Hounoum, P. H. Gordon, P. Vourc'h, C. R. Andres & P. Corcia. (2016) Metabolomics in amyotrophic lateral sclerosis: how far can it take us?. European Journal of Neurology 23:3, pages 447-454.
Crossref
Crossref
Diana Caballero-Hernandez, Miguel G. Toscano, Marta Cejudo-Guillen, Maria L. Garcia-Martin, Soledad Lopez, Jaime M. Franco, Francisco J. Quintana, Cintia Roodveldt & David Pozo. (2016) The ‘Omics’ of Amyotrophic Lateral Sclerosis. Trends in Molecular Medicine 22:1, pages 53-67.
Crossref
Crossref
Alexandre Henriques, Vincent Croixmarie, David A. Priestman, Angela Rosenbohm, Sylvie Dirrig-Grosch, Eleonora D'Ambra, Mylene Huebecker, Ghulam Hussain, Claire Boursier-Neyret, Andoni Echaniz-Laguna, Albert C. Ludolph, Frances M. Platt, Bernard Walther, Michael Spedding, Jean-Philippe Loeffler & Jose-Luis Gonzalez De Aguilar. (2015) Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Human Molecular Genetics 24:25, pages 7390-7405.
Crossref
Crossref
F. Patin, P. Corcia, B. Madji Hounoum, C. Veyrat‐Durebex, E. Respaud, E. Piver, I. Benz‐de Bretagne, P. Vourc'h, C. R. Andres & H. Blasco. (2015) Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. European Journal of Neurology 22:10, pages 1385-1390.
Crossref
Crossref
Clara Ibáñez, Alejandro Cifuentes & Carolina Simó. 2015. Omic Studies of Neurodegenerative Disease: Part B. Omic Studies of Neurodegenerative Disease: Part B
95
132
.
Nazem AtassiJames BerryAmy ShuiNeta ZachAlexander ShermanErvin SinaniJason WalkerIgor KatsovskiyDavid SchoenfeldMerit CudkowiczMelanie Leitner. (2014) The PRO-ACT database. Neurology 83:19, pages 1719-1725.
Crossref
Crossref
Axel Freischmidt, Kathrin Müller, Lisa Zondler, Patrick Weydt, Alexander E. Volk, Anže Lošdorfer Božič, Michael Walter, Michael Bonin, Benjamin Mayer, Christine A. F. von Arnim, Markus Otto, Christoph Dieterich, Karlheinz Holzmann, Peter M. Andersen, Albert C. Ludolph, Karin M. Danzer & Jochen H. Weishaupt. (2014) Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain 137:11, pages 2938-2950.
Crossref
Crossref
Xueping Chen, Xiaoyan Guo, Rui Huang, Zhenzhen Zheng, Yongping Chen & Hui-fang Shang. (2014) An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis. Neurological Sciences 35:10, pages 1591-1597.
Crossref
Crossref
Kathryne Kirk, Chris Gennings, Jonathan C. Hupf, Saba Tadesse, Marilena D'Aurelio, Hibiki Kawamata, Federica Valsecchi, Hiroshi Mitsumoto & Giovanni Manfredi. (2014) Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Annals of Neurology 76:4, pages 620-624.
Crossref
Crossref
Mariona Jové, Manuel Portero-Otín, Alba Naudí, Isidre Ferrer & Reinald Pamplona. (2014) Metabolomics of Human Brain Aging and Age-Related Neurodegenerative Diseases. Journal of Neuropathology & Experimental Neurology 73:7, pages 640-657.
Crossref
Crossref
Hélène Blasco, Philippe Corcia & Pierre-François Pradat. (2014) L’utilisation de biomarqueurs dans la SLA est-elle d’actualité ?. La Presse Médicale 43:5, pages 569-579.
Crossref
Crossref
Hélène BlascoLydie Nadal-DesbaratsPierre-François PradatPaul H. GordonCatherine AntarCharlotte Veyrat-DurebexCaroline MoreauDavid DevosSylvie MavelPatrick EmondChristian R. AndresPhilippe Corcia. (2014)
Untargeted
1
H-NMR metabolomics in CSF
. Neurology 82:13, pages 1167-1174.
Crossref
Crossref
Laura Robelin & Jose Luis Gonzalez De Aguilar. (2014) Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Paul L Wood. (2013) Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology. Neuropsychopharmacology 39:1, pages 24-33.
Crossref
Crossref
Monica Bame, Robert E. Grier, Richard Needleman & William S.A. Brusilow. (2014) Amino Acids as biomarkers in the SOD1G93A mouse model of ALS. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:1, pages 79-87.
Crossref
Crossref
Axel Freischmidt, Kathrin Müller, Albert C Ludolph & Jochen H Weishaupt. (2013) Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathologica Communications 1:1.
Crossref
Crossref
Hélène Blasco, Philippe CorciaPaul H Gordon & Pierre-François Pradat. (2013) Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond. Neurodegenerative Disease Management 3:5, pages 427-444.
Crossref
Crossref
Hélène Blasco, Philippe Corcia, Pierre-François Pradat, Cinzia Bocca, Paul H. Gordon, Charlotte Veyrat-Durebex, Sylvie Mavel, Lydie Nadal-Desbarats, Caroline Moreau, David Devos, Christian R. Andres & Patrick Emond. (2013) Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry. Journal of Proteome Research 12:8, pages 3746-3754.
Crossref
Crossref
Dione T. Kobayashi, Jing Shi, Laurie Stephen, Karri L. Ballard, Ruth Dewey, James Mapes, Brett Chung, Kathleen McCarthy, Kathryn J. Swoboda, Thomas O. Crawford, Rebecca Li, Thomas Plasterer, Cynthia Joyce, Wendy K. Chung, Petra Kaufmann, Basil T. Darras, Richard S. Finkel, Douglas M. Sproule, William B. Martens, Michael P. McDermott, Darryl C. De Vivo, Michael G. Walker & Karen S. Chen. (2013) SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy. PLoS ONE 8:4, pages e60113.
Crossref
Crossref
Marlia M. Braun, Matt Osecheck & Nanette C. Joyce. (2012) Nutrition Assessment and Management in Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 23:4, pages 751-771.
Crossref
Crossref